PDL BioPharma, Inc.Redwood City, CA, United States (NASDAQ (GS): PDLI)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

PDL Financial Statements

PDL Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

PDL Income Statement

  2007 2006 2005
Revenue ($ mil.) 258.9 414.8 279.6
Gross Profit ($ mil.) -- 328.5 219.4
Operating Income ($ mil.) (24.8) (133.9) (165.1)
Total Net Income ($ mil.) (21.1) (130.0) (166.6)
Diluted EPS (Net Income) (0.18) (1.14) (1.60)
More PDL financial information

PDL Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08* Quarter Ending Sep 07
Revenue ($ mil.) 111.9 57.3 110.1
Gross Profit ($ mil.) -- -- 93.3
Operating Income ($ mil.) 51.7 29.7 (7.7)
Total Net Income ($ mil.) 33.9 (61.9) (5.8)
Diluted EPS (Net Income) 0.26 (0.42) (0.10)
  • * Irregular reporting interval
More PDL financial information

PDL Stock Quote & Chart

08/21/08 15:00:10 EST • NASDAQ • 12.54 • Increased by +0.1000 • Increased by +0.8039 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

PDL Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 5.43 3.69 1.54
Price/Earnings Ratio -- 15.22 15.51
Price/Book Ratio 2.77 2.94 1.48
Price/Cash Flow Ratio 20.99 12.49 9.68
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed PDL Financial Ratios

PDL Competitive Intelligence

Medarex Seattle Genetics XOMA
Annual Sales ($ mil.) 56.3 22.4 84.3
Employees 500 -- --
Market Cap ($ mil.) 1,134.5 962.9 305.7

Competitive Landscape